Gerresheimer, a global partner for the pharma, biotech, and cosmetic industries, has once again been awarded Gold by sustainability rating provider EcoVadis, improving its overall score from 78 in 2025 to 82 out of 100 points. The improved rating places Gerresheimer among the top 5% of all companies evaluated by EcoVadis and within the top 2% in its industry. The company also ranks in the top 1% for sustainable procurement, underscoring the importance of responsible supply chains. This achievement matters because it demonstrates Gerresheimer's commitment to sustainability and provides customers with independent validation of its performance.
EcoVadis evaluates more than 175,000 companies annually across environment, labor and human rights, ethics, and sustainable procurement. Gerresheimer has relied on EcoVadis since 2011, first achieving Gold in 2022 with a score of 68. The latest rating reflects continuous improvement. "With the improved EcoVadis rating and our first voluntary report based on the CSRD, we are making our sustainability performance measurable and transparent for our customers," said Wolf Lehmann, CFO of Gerresheimer AG. "We remain committed to consistently pursuing our ambitious sustainability targets in the future."
The EcoVadis assessment framework is based on international standards including the UN Global Compact, ILO conventions, GRI standards, ISO 26000, and the UN Guiding Principles on Business and Human Rights. This rigorous methodology ensures that the rating is credible and comparable across industries. For Gerresheimer, the Gold rating signals to investors, customers, and partners that its sustainability management is robust. It also aligns with the company's ambitious targets in climate protection, circular economy, responsible supply chains, and social responsibility.
For the 2025 financial year, Gerresheimer voluntarily submitted an audited non-financial consolidated report based on the Corporate Sustainability Reporting Directive (CSRD), significantly advancing its reporting structure. The report is available for download here. Additionally, Gerresheimer discloses data annually on the EcoVadis platform and participates in the CDP rating, with evaluations from MSCI, Sustainalytics, and ISS. An overview of these external assessments is available here.
The improved rating and transparent reporting are important for the industry as they set a benchmark for sustainability practices. Companies in the pharma and biotech supply chain face increasing pressure to demonstrate responsible operations. Gerresheimer's performance may influence procurement decisions and investor confidence. For readers, this news highlights the growing importance of sustainability ratings in business, especially in highly regulated sectors where environmental and social governance are critical. As Gerresheimer continues to pursue its targets, its progress will be closely watched. The original release is available on www.newmediawire.com.
